9 results
#Diagnosis #EM #IM #PERC #Low #Risk #Pulmonary #Embolism #PulmonaryEmbolism #Algorithm #RebelEM
#Diagnosis #EM # ... IM #PERC #Low #Risk ... #Pulmonary #Embolism ... #PulmonaryEmbolism ... #Algorithm #RebelEM
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Pulmonary Embolism ... mortality #Diagnosis #Management ... #EM #IM #PCC #PESI ... #sPESI #risk #score ... #PE #PulmonaryEmbolism
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... of Suspected Pulmonary ... Embolism #Diagnosis ... #EM #IM #PCC #PulmonaryEmbolism ... #Pulmonary #Embolism
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Embolism • Provoked ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
HESTIA Criteria for Outpatient Pulmonary Embolism Treatment - Identifies low-risk PE patients safe for outpatient treatment
for Outpatient Pulmonary ... Embolism Treatment ... Identifies low-risk ... #Diagnosis #Management ... #Criteria #PE #PulmonaryEmbolism
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... thrombosis; PE = pulmonary ... embolism; GI = ... Anticoagulation #Management
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
Diagnosis and Management ... Algorithm STEMI ... Limb ischemia Pulmonary ... Embolism: - Hx ... #Algorithm #differential
A possible diagnostic algorithm for pulmonary embolism in pregnancy (equipose)

Given the variability in guidelines and equipoise
possible diagnostic algorithm ... for pulmonary embolism ... the benefits and risks ... Obstetrics #Radiology #PulmonaryEmbolism ... Workup #Imaging #Algorithm
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... #diagnosis #management